These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25698585)

  • 21. A positron emission tomography study of memories of childhood abuse in borderline personality disorder.
    Schmahl CG; Vermetten E; Elzinga BM; Bremner JD
    Biol Psychiatry; 2004 Apr; 55(7):759-65. PubMed ID: 15039006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study.
    Sacher J; Rabiner EA; Clark M; Rusjan P; Soliman A; Boskovic R; Kish SJ; Wilson AA; Houle S; Meyer JH
    J Cereb Blood Flow Metab; 2012 Mar; 32(3):443-6. PubMed ID: 22186668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography.
    Baldinger-Melich P; Gryglewski G; Philippe C; James GM; Vraka C; Silberbauer L; Balber T; Vanicek T; Pichler V; Unterholzner J; Kranz GS; Hahn A; Winkler D; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Frey R; Lanzenberger R
    Brain Stimul; 2019; 12(3):714-723. PubMed ID: 30635228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure.
    Matthews BA; Tong J; Attwells S; Xu X; Le A; Kish SJ; Meyer JH
    Drug Alcohol Depend; 2018 Apr; 185():398-405. PubMed ID: 29549852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychobiology of borderline personality traits related to subtypes of eating disorders: a study of platelet MAO activity.
    Díaz-Marsá M; Carrasco JL; de Anta L; Molina R; Sáiz J; Cesar J; López-Ibor JJ
    Psychiatry Res; 2011 Dec; 190(2-3):287-90. PubMed ID: 21658781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography in female patients with borderline personality disorder.
    Juengling FD; Schmahl C; Hesslinger B; Ebert D; Bremner JD; Gostomzyk J; Bohus M; Lieb K
    J Psychiatr Res; 2003; 37(2):109-15. PubMed ID: 12842164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline Personality Disorder With Depression Confers Significant Risk of Suicidal Behavior in Mood Disorder Patients-A Comparative Study.
    Söderholm JJ; Socada JL; Rosenström T; Ekelund J; Isometsä ET
    Front Psychiatry; 2020; 11():290. PubMed ID: 32362847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain.
    Ginovart N; Meyer JH; Boovariwala A; Hussey D; Rabiner EA; Houle S; Wilson AA
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):330-44. PubMed ID: 16079787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the contribution of borderline personality disorder and features to suicide risk in psychiatric inpatients with bipolar disorder, major depression and schizoaffective disorder.
    Zeng R; Cohen LJ; Tanis T; Qizilbash A; Lopatyuk Y; Yaseen ZS; Galynker I
    Psychiatry Res; 2015 Mar; 226(1):361-7. PubMed ID: 25661531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy.
    Spies M; James GM; Vraka C; Philippe C; Hienert M; Gryglewski G; Komorowski A; Kautzky A; Silberbauer L; Pichler V; Kranz GS; Nics L; Balber T; Baldinger-Melich P; Vanicek T; Spurny B; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R; Winkler D
    Transl Psychiatry; 2018 Sep; 8(1):198. PubMed ID: 30242221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borderline personality disorder and depression severity predict suicidal outcomes: A six-month prospective cohort study of depression, bipolar depression, and borderline personality disorder.
    Söderholm JJ; Socada JL; Rosenström TH; Ekelund J; Isometsä E
    Acta Psychiatr Scand; 2023 Sep; 148(3):222-232. PubMed ID: 37438939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prefrontal cortex engagement during an fMRI task of emotion regulation as a potential predictor of treatment response in borderline personality disorder.
    Michel CA; Schneck N; Mann JJ; Ochsner KN; Brodsky BS; Stanley B
    J Affect Disord; 2024 Nov; 364():240-248. PubMed ID: 39142579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [
    Zanderigo F; D'Agostino AE; Joshi N; Schain M; Kumar D; Parsey RV; DeLorenzo C; Mann JJ
    Mol Imaging Biol; 2018 Aug; 20(4):667-681. PubMed ID: 29423903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls.
    Hoerst M; Weber-Fahr W; Tunc-Skarka N; Ruf M; Bohus M; Schmahl C; Ende G
    Arch Gen Psychiatry; 2010 Sep; 67(9):946-54. PubMed ID: 20603446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of MAOA DNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission Tomography.
    Handschuh PA; Murgaš M; Vraka C; Nics L; Hartmann AM; Winkler-Pjrek E; Baldinger-Melich P; Wadsak W; Winkler D; Hacker M; Rujescu D; Domschke K; Lanzenberger R; Spies M
    Int J Neuropsychopharmacol; 2023 Feb; 26(2):116-124. PubMed ID: 36573644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine Oxidase A in Antisocial Personality Disorder and Borderline Personality Disorder.
    Kolla NJ; Vinette SA
    Curr Behav Neurosci Rep; 2017; 4(1):41-48. PubMed ID: 29568721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anterior cingulate volume reduction in adolescents with borderline personality disorder and co-morbid major depression.
    Goodman M; Hazlett EA; Avedon JB; Siever DR; Chu KW; New AS
    J Psychiatr Res; 2011 Jun; 45(6):803-7. PubMed ID: 21145068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study.
    Soloff P; Nutche J; Goradia D; Diwadkar V
    Psychiatry Res; 2008 Dec; 164(3):223-36. PubMed ID: 19019636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of abnormal brain volume in major depressive disorder: a comparison with borderline personality disorder.
    Depping MS; Wolf ND; Vasic N; Sambataro F; Thomann PA; Christian Wolf R
    J Affect Disord; 2015 Mar; 174():650-7. PubMed ID: 25577159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder.
    Attwells S; Setiawan E; Rusjan PM; Xu C; Hutton C; Rafiei D; Varughese B; Kahn A; Kish SJ; Vasdev N; Houle S; Meyer JH
    Biol Psychiatry; 2020 Oct; 88(8):649-656. PubMed ID: 32402468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.